Turner, Oliver, Morton, Dan, Sistare, Frank, Nambiar, Prashant, Zaher, Radi and Bower, Nancy (2014) Alternative Mouse Models for Future Cancer Risk Assessment. Toxicologic Pathology, 42 (5). pp. 1-8.

Abstract

*This commentary was created by members of the limited duration key issues team that supports the representatives of the Pharmaceutical Research and Manufacturers Association on the ICH S1 Expert Working Group. This is an opinion article submitted to the Regulatory Forum and does not constitute an official position of the Society of Toxicologic Pathology or the journal Toxicologic Pathology. The views expressed in this article are those of the authors and do not necessarily represent the policies, positions or opinions of their respective agencies and organizations. The Regulatory Forum is designed to stimulate broad discussion of topics relevant to regulatory issues in toxicologic pathology. Readers of Toxicologic Pathology are encouraged to send their thoughts on these articles or ideas for new topics to regulatoryforum@toxpath.org.

Item Type:	Article
Keywords:	carcinogenicity, guidance, ICH S1, mouse, p53+/-, pharmaceutical, rasH2, rodent
Date Deposited:	23 Jun 2016 23:45
Last Modified:	23 Jun 2016 23:45
URI:	https://oak.novartis.com/id/eprint/10286